Grants will fund tuberculosis drug development : vimarsana.c

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis (TB) drug development. This effort will expedite finding new drug targets

Related Keywords

, Dirk Schnappinger , Sabine Ehrt , Michael Glickman , Carlf Nathan , Sloan Kettering Institute , Pathogen Biology At Rockefeller University , World Health Organization , Melinda Gates Foundation , Laboratory Of Host , Weill Cornell Medicine , World Health , Jeremy Rock , Host Pathogen Biology , Cornell Medicine ,